Taylor Triolo
Last active: 3/29/2019

Profile

None provided

Publications

The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Identical and Nonidentical Twins: Risk and Factors Involved in Development of Islet Autoimmunity and Type 1 Diabetes. Triolo TM, Fouts A, Pyle L, Yu L, Gottlieb PA, Steck AK, Type 1 Diabetes TrialNet Study Group (2019) Diabetes Care 42(2): 192-199
    › Primary publication · 30061316 (PubMed) · PMC6341285 (PubMed Central)
  2. Effects of Frequency of Sensor-Augmented Pump Use on HbA1c and C-Peptide Levels in the First Year of Type 1 Diabetes. Triolo TM, Maahs DM, Pyle L, Slover R, Buckingham B, Cheng P, DiMeglio LA, Bremer AA, Weinzimer SA, Chase HP, Diabetes Research in Children Network (DirecNet) and Type 1 Diabetes TrialNet Study Groups (2016) Diabetes Care 39(4): e61-2
    › Primary publication · 26895885 (PubMed) · PMC4806776 (PubMed Central)
  3. Etiology of insulin resistance in youth with type 2 diabetes. Cree-Green M, Triolo TM, Nadeau KJ (2013) Curr Diab Rep 13(1): 81-8
    › Primary publication · 23135953 (PubMed) · PMC4296020 (PubMed Central)
  4. Dominant suppression of Addison's disease associated with HLA-B15. Baker PR, Baschal EE, Fain PR, Nanduri P, Triolo TM, Siebert JC, Armstrong TK, Babu SR, Rewers MJ, Gottlieb PA, Barker JM, Eisenbarth GS (2011) J Clin Endocrinol Metab 96(7): 2154-62
    › Primary publication · 21565792 (PubMed) · PMC3135206 (PubMed Central)
  5. Additional autoimmune disease found in 33% of patients at type 1 diabetes onset. Triolo TM, Armstrong TK, McFann K, Yu L, Rewers MJ, Klingensmith GJ, Eisenbarth GS, Barker JM (2011) Diabetes Care 34(5): 1211-3
    › Primary publication · 21430083 (PubMed) · PMC3114477 (PubMed Central)
  6. Haplotype analysis discriminates genetic risk for DR3-associated endocrine autoimmunity and helps define extreme risk for Addison's disease. Baker PR, Baschal EE, Fain PR, Triolo TM, Nanduri P, Siebert JC, Armstrong TK, Babu SR, Rewers MJ, Gottlieb PA, Barker JM, Eisenbarth GS (2010) J Clin Endocrinol Metab 95(10): E263-70
    › Primary publication · 20631027 (PubMed) · PMC3050098 (PubMed Central)
  7. Homozygosity of the polymorphism MICA5.1 identifies extreme risk of progression to overt adrenal insufficiency among 21-hydroxylase antibody-positive patients with type 1 diabetes. Triolo TM, Baschal EE, Armstrong TK, Toews CS, Fain PR, Rewers MJ, Yu L, Miao D, Eisenbarth GS, Gottlieb PA, Barker JM (2009) J Clin Endocrinol Metab 94(11): 4517-23
    › Primary publication · 19820007 (PubMed) · PMC2775653 (PubMed Central)
  8. Diabetic subjects diagnosed through the Diabetes Prevention Trial-Type 1 (DPT-1) are often asymptomatic with normal A1C at diabetes onset. Triolo TM, Chase HP, Barker JM, DPT-1 Study Group (2009) Diabetes Care 32(5): 769-73
    › Primary publication · 19407074 (PubMed) · PMC2671125 (PubMed Central)
  9. Two single nucleotide polymorphisms identify the highest-risk diabetes HLA genotype: potential for rapid screening. Barker JM, Triolo TM, Aly TA, Baschal EE, Babu SR, Kretowski A, Rewers MJ, Eisenbarth GS (2008) Diabetes 57(11): 3152-5
    › Primary publication · 18694972 (PubMed) · PMC2570414 (PubMed Central)